Pre-Clinical Efficacy of a Selective p38MAPK Inhibitor in a Model of Comorbid Alzheimer/Vascular Pathology

Medicine and Dentistry

1. Alzheimer's Disease 100%
2. Vascular Disease 100%
3. Cognitive Defect 100%
4. Neuroinflammation 22%
5. Sequela 22%
6. Cerebrovascular Disease 22%
7. p38 Mitogen-Activated Protein Kinase 22%
8. Transgenic Mouse 22%
9. Diseases 22%
10. Patient with Alzheimer's Disease 11%
11. Immunocompetent Cell 11%
12. Disease Exacerbation 11%
13. Pathology of Alzheimer's Disease 11%
14. Blood Vessel Injury 11%
15. Pathophysiology 11%
16. Cell Signaling Pathway 11%
17. Hyperhomocysteinemia 11%
18. Clinical Stage 11%
19. Monotherapy 11%
20. Serositis 11%
21. Microglia 11%
22. Protein Kinases 11%
23. Comorbidity 11%